These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1447221)

  • 1. The crystal structure of the aldose reductase.NADPH binary complex.
    Borhani DW; Harter TM; Petrash JM
    J Biol Chem; 1992 Dec; 267(34):24841-7. PubMed ID: 1447221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel NADPH-binding domain revealed by the crystal structure of aldose reductase.
    Rondeau JM; Tête-Favier F; Podjarny A; Reymann JM; Barth P; Biellmann JF; Moras D
    Nature; 1992 Jan; 355(6359):469-72. PubMed ID: 1734286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of porcine aldehyde reductase holoenzyme.
    el-Kabbani O; Judge K; Ginell SL; Myles DA; DeLucas LJ; Flynn TG
    Nat Struct Biol; 1995 Aug; 2(8):687-92. PubMed ID: 7552731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of human aldehyde reductase: characterization of the active site pocket.
    Barski OA; Gabbay KH; Grimshaw CE; Bohren KM
    Biochemistry; 1995 Sep; 34(35):11264-75. PubMed ID: 7669785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human aldose reductase: rate constants for a mechanism including interconversion of ternary complexes by recombinant wild-type enzyme.
    Grimshaw CE; Bohren KM; Lai CJ; Gabbay KH
    Biochemistry; 1995 Nov; 34(44):14356-65. PubMed ID: 7578039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The coenzyme specificity of Candida tenuis xylose reductase (AKR2B5) explored by site-directed mutagenesis and X-ray crystallography.
    Petschacher B; Leitgeb S; Kavanagh KL; Wilson DK; Nidetzky B
    Biochem J; 2005 Jan; 385(Pt 1):75-83. PubMed ID: 15320875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldehyde reductase: the role of C-terminal residues in defining substrate and cofactor specificities.
    Rees-Milton KJ; Jia Z; Green NC; Bhatia M; El-Kabbani O; Flynn TG
    Arch Biochem Biophys; 1998 Jul; 355(2):137-44. PubMed ID: 9675019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the active site of human aldose reductase. Site-directed mutagenesis of Asp-43, Tyr-48, Lys-77, and His-110.
    Tarle I; Borhani DW; Wilson DK; Quiocho FA; Petrash JM
    J Biol Chem; 1993 Dec; 268(34):25687-93. PubMed ID: 8245005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unlikely sugar substrate site in the 1.65 A structure of the human aldose reductase holoenzyme implicated in diabetic complications.
    Wilson DK; Bohren KM; Gabbay KH; Quiocho FA
    Science; 1992 Jul; 257(5066):81-4. PubMed ID: 1621098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldose and aldehyde reductases: structure-function studies on the coenzyme and inhibitor-binding sites.
    El-Kabbani O; Old SE; Ginell SL; Carper DA
    Mol Vis; 1999 Sep; 5():20. PubMed ID: 10493777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of Escherichia coli thioredoxin reductase refined at 2 A resolution. Implications for a large conformational change during catalysis.
    Waksman G; Krishna TS; Williams CH; Kuriyan J
    J Mol Biol; 1994 Feb; 236(3):800-16. PubMed ID: 8114095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residues affecting the catalysis and inhibition of rat lens aldose reductase.
    Carper DA; Hohman TC; Old SE
    Biochim Biophys Acta; 1995 Jan; 1246(1):67-73. PubMed ID: 7811733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
    Roitel O; Scrutton NS; Munro AW
    Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on pig aldose reductase. Identification of an essential arginine in the primary and tertiary structure of the enzyme.
    Kubiseski TJ; Green NC; Borhani DW; Flynn TG
    J Biol Chem; 1994 Jan; 269(3):2183-8. PubMed ID: 8294474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase.
    Nakano T; Petrash JM
    Biochemistry; 1996 Aug; 35(34):11196-202. PubMed ID: 8780524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The alrestatin double-decker: binding of two inhibitor molecules to human aldose reductase reveals a new specificity determinant.
    Harrison DH; Bohren KM; Petsko GA; Ringe D; Gabbay KH
    Biochemistry; 1997 Dec; 36(51):16134-40. PubMed ID: 9405046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An anion binding site in human aldose reductase: mechanistic implications for the binding of citrate, cacodylate, and glucose 6-phosphate.
    Harrison DH; Bohren KM; Ringe D; Petsko GA; Gabbay KH
    Biochemistry; 1994 Mar; 33(8):2011-20. PubMed ID: 8117658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic alteration of human aldose reductase by mutagenesis of cysteine residues.
    Petrash JM; Harter T; Tarle I; Borhani D
    Adv Exp Med Biol; 1993; 328():289-300. PubMed ID: 8493906
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of human aldose and aldehyde reductases. Site-directed mutagenesis of a critical lysine 262.
    Bohren KM; Page JL; Shankar R; Henry SP; Gabbay KH
    J Biol Chem; 1991 Dec; 266(35):24031-7. PubMed ID: 1748675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldose reductase as a target for drug design: molecular modeling calculations on the binding of acyclic sugar substrates to the enzyme.
    De Winter HL; von Itzstein M
    Biochemistry; 1995 Jul; 34(26):8299-308. PubMed ID: 7599122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.